#
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Unrestricted|
|---|---|---|---|---|
||||funds|funds|
||||2022|2021|
|||Notes|||
|Income from:|||||
|Donations
and legacies|||59,048|77,902|
|Investments|||43|58|
|Total income|||59,091|77,960|
|~Edit|||||
|Nurses purchases||4|21,840|29,218|
|Net income for the year/|||||
|Net movement|in funds||37,251|48,742|
|Fund balances at 1 July 2021|||247,172|198,430|
|Fund balances|at 30June 2022||284,423|247,172|
##
##
##
||||2022||2021||
|---|---|---|---|---|---|---|
|||Notes|8||8||
|Current assets|||||||
|Cash at bank and in|hand||285,123||247,872||
|Creditors: amounts
one year|falling due within|8|(700)||(700)||
|Net current assets||||284,423||247,172|
|Income funds|||||||
|Unrestricted
funds||||284,423||247,172|
|||||284,423||247,172|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|2|Donations|and legacies|||
|---|---|---|---|---|
||||Unrestricted|Unrestricted|
||||funds|funds|
||||2022|2021|
||||F||
||Donations
Legacies|and gifts
receivable|485
58,563|47,902
30,000|
||||59,048|77,902|
|3|Investments||||
||||Unrestricted|Unrestricted|
||||funds|funds|
||||2022|2021|
||||F|9|
||Interest receivable||43|58|
##
##
##
||||2022f|2021f|
|---|---|---|---|---|
|Liquid|nitrogen||3,352|2,512|
|Other|purchases||17,888|26,056|
||||21,240|28,568|
|Share|ofgovernance|costs (see note 5)|600|650|
||||21,840|29,218|
##
|Support|c|osts||||||
|---|---|---|---|---|---|---|---|
|||||Support|Governance|2022|2021|
|||||Costs|COStSf|||
|Independent||examiners|fee||600|600|650|
||||||600|600|650|
|Analysed|between|||||||
|Charitable||activities|||600|600|650|
##
##
||The average
monthly|num|ber ofemploye|es
during the|year was:|||
|---|---|---|---|---|---|---|---|
|||||||2022|2021|
|||||||Number|Number|
||Tote I|||||||
||There were no employees||whose annual|remuneration|was more than f60,000.|||
|8|Creditors: amounts|falling due within||one year||||
|||||||2022f|2021f|
||Accruals and deferred|income||||700|700|
##
#